Eric H. L. So
CIK: 0002116526
Transaction Breakdown
Open Market Buys (P)3 (75.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HELP
Helus Pharma Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 30, 2026HELP
Helus Pharma Inc.
Award(A)Direct248K shares- - Sep 8, 2026CYBN
CYBIN INC.
Purchase(P)Direct100K shares at avg. $12.39$1.2M - Sep 4, 2026CYBN
CYBIN INC.
Purchase(P)Direct100K shares at avg. $12.09$1.2M - Sep 1, 2026CYBN
CYBIN INC.
Purchase(P)Direct95K shares at avg. $11.80$1.1M
1-4 of 4 transactions
About So Eric H. L.
So Eric H. L. (SEC CIK 0002116526) files insider reports with the SEC as Director of Helus Pharma Inc. (HELP).
Signal8 holds 5 ownership filings by So Eric H. L. (1 Form 3, 4 Form 4), filed between Sep 9, 2026 and Oct 1, 2026. Those filings report 4 transactions, from Sep 1, 2026 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on So Eric H. L.'s filings is in TORONTO.
Recent filings by So Eric H. L.
Other insiders filing for Helus Pharma Inc. (HELP)
- Durgam Suresh K., Director
- Lewis-Hall Freda C, Director
- Inamdar Amir, Director
- Froese Grant, Director
- Hoskins Eric, Director
- Lawson Mark, Director